Kevin M. Beussman

Kevin M. Beussman

Auto-generated profile, based on publicly available information

Kevin M. Beussman

University of Washington

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
ALAndrea Leonard
Andrea Leonard
ABAlessandro Bertero
Alessandro Bertero
JPJoseph D. Powers
Joseph D. Powers
KBKevin M. Beussman
Kevin M. Beussman
SBShiv Bhandari
Shiv Bhandari
NSNathan Sniadecki
Nathan Sniadecki

24 December 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CCCongwu Chi
Congwu Chi
ALAndrea Leonard
Andrea Leonard
WKWalter E. Knight
Walter E. Knight
KBKevin M. Beussman
Kevin M. Beussman
YZYuanbiao Zhao
Yuanbiao Zhao
KSKunhua Song
Kunhua Song
Mutations in lysosomal-associated membrane protein 2 ( LAMP-2 ) gene are associated with Danon disease, which often leads to cardiomyopathy/heart failure through poorly defined mechanisms. Here, we identify the LAMP-2 isoform B (LAMP-2B) as required for autophagosome–lysosome fusion in human cardiomyocytes (CMs). Remarkably, LAMP-2B functions independently of syntaxin 17 (STX17), a protein that is essential for autophagosome–lysosome fusion in non-CMs. Instead, LAMP-2B interacts with autophagy related 14 (ATG14) and vesicle-associated membrane protein 8 (VAMP8) through its C-terminal coiled coil domain (CCD) to promote autophagic fusion. CMs derived from induced pluripotent stem cells (hiPSC-CMs) from Danon patients exhibit decreased colocalization between ATG14 and VAMP8, profound defects in autophagic fusion, as well as mitochondrial and contractile abnormalities. This phenotype was recapitulated by LAMP-2B knockout in non-Danon hiPSC-CMs. Finally, gene correction of LAMP-2 mutation rescues the Danon phenotype. These findings reveal a STX17-independent autophagic fusion mechanism in human CMs, providing an explanation for cardiomyopathy in Danon patients and a foundation for targeting defective LAMP-2B–mediated autophagy to treat this patient population.

1 February 2016 in Methods
Verified
Journal Article
Closed access
KBKevin M. Beussman
Kevin M. Beussman
MRMarita L. Rodriguez
Marita L. Rodriguez
ALAndrea Leonard
Andrea Leonard
NTNikita Taparia
Nikita Taparia
CTCurtis R. Thompson
Curtis R. Thompson
NSNathan Sniadecki
Nathan Sniadecki

8 August 2019 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ABAlessandro Bertero
Alessandro Bertero
PFPaul A. Fields
Paul A. Fields
ASAlec S.T. Smith
Alec S.T. Smith
ALAndrea Leonard
Andrea Leonard
KBKevin Beussman
Kevin Beussman
CMCharles E. Murry
Charles E. Murry
Mutations in A-type nuclear lamins cause dilated cardiomyopathy, which is postulated to result from dysregulated gene expression due to changes in chromatin organization into active and inactive compartments. To test this, we performed genome-wide chromosome conformation analyses in human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) with a haploinsufficient mutation for lamin A/C. Compared with gene-corrected cells, mutant hiPSC-CMs have marked electrophysiological and contractile alterations, with modest gene expression changes. While large-scale changes in chromosomal topology are evident, differences in chromatin compartmentalization are limited to a few hotspots that escape segregation to the nuclear lamina and inactivation during cardiogenesis. These regions exhibit up-regulation of multiple noncardiac genes including CACNA1A, encoding for neuronal P/Q-type calcium channels. Pharmacological inhibition of the resulting current partially mitigates the electrical alterations. However, chromatin compartment changes do not explain most gene expression alterations in mutant hiPSC-CMs. Thus, global errors in chromosomal compartmentation are not the primary pathogenic mechanism in heart failure due to lamin A/C haploinsufficiency.

1 June 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
KBKevin M. Beussman
Kevin M. Beussman
MMMolly Y. Mollica
Molly Y. Mollica
ALAndrea Leonard
Andrea Leonard
JMJeffrey Miles
Jeffrey Miles
JHJohn Hocter
John Hocter
NSNathan Sniadecki
Nathan Sniadecki

20 April 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
DEDanny El-Nachef
Danny El-Nachef
DBDarrian Bugg
Darrian Bugg
KBKevin M. Beussman
Kevin M. Beussman
SSSonette Steczina
Sonette Steczina
AMAmy M. Martinson
Amy M. Martinson
JDJennifer Davis
Jennifer Davis